Identifying Genetic Regulators of Protein‐Glycan Interactions with Genome‐Wide CRISPR Screening

Author:

Krishnamoorthy Vignesh1,Daly John1,Wisnovsky Simon1

Affiliation:

1. Faculty of Pharmaceutical Sciences University of British Columbia Vancouver Canada

Abstract

AbstractGlycans are carbohydrate molecules appended to proteins and lipids on the surface of all living cells. Glycans play key roles in a wide array of biological processes, and structural changes in cell‐surface glycosylation patterns have been connected to pathogenesis of several diseases. In particular, cancer cells frequently upregulate expression of glycans that bind to inhibitory receptors (lectins) on immune cells. These glycosylated antigens systematically inhibit immune activity and protect cancer cells from immune surveillance. Understanding how cancer cells generate these glycan ligands can thus lead to identification of novel druggable targets for therapeutic intervention. However, glycan ligand biosynthesis is subject to extremely complex genetic regulation, making it difficult to identify the key genes involved in production of immune‐regulatory glycan antigens. In a recent publication, we described a CRISPR/Cas9 screening approach to identify genes that drive synthesis of ligands for glycan‐binding immune receptors. Here, we outline a detailed, step‐by‐step protocol for completing this type of genome‐wide screen. Our protocol produces a genome‐wide atlas of all genes whose expression is required for cell‐surface binding of a recombinant immune lectin. This dataset can be used both to identify novel ligands for immune lectins and annotate regulatory genes that drive changes in cancer‐associated glycosylation. Our protocol serves as a general resource for researchers interested in the detailed study of cancer glyco‐immunology. © 2023 Wiley Periodicals LLC.Basic Protocol 1: Generation of a genome‐wide CRISPR library using lentiviral transductionSupport Protocol: Generation of dCas9KRAB‐expressing K‐562 cellsBasic Protocol 2: Staining of genome‐wide CRISPR libraries with Siglec‐Fc reagents and fluorescence‐activated cell sortingBasic Protocol 3: Library amplification and sequencingBasic Protocol 4: Data analysis and hit identification

Funder

Canadian Institutes of Health Research

Natural Sciences and Engineering Research Council of Canada

Publisher

Wiley

Subject

Medical Laboratory Technology,Health Informatics,General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3